There is no abstract available.


Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. Bayliss WM, Starling EH. 1.  1902. The mechanism of pancreatic secretion. J. Physiol. 28:325–53 [Google Scholar]
  2. Rehfeld JF. 2.  2012. Beginnings: a reflection on the history of gastrointestinal endocrinology. Regul. Pept. 177:Suppl.1–5 [Google Scholar]
  3. Banting FG, Best CH. 3.  1922. The internal secretion of the pancreas. J. Lab. Clin. Med. 7:256–71 [Google Scholar]
  4. Bromer WW, Sinn LG, Staub A, Behrens OK. 4.  1957. The amino acid sequence of glucagon. Diabetes 6:234–38 [Google Scholar]
  5. Crockford PM, Yakimets WW, Salsberg B, Johnson SA, Joseph P. 5.  1971. Glucagon: a “contaminant” comes of age. Can. Med. Assoc. J. 105:963–68 [Google Scholar]
  6. Brazeau P, Vale W, Burgus R, Ling N, Butcher M. 6.  et al. 1973. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77–79 [Google Scholar]
  7. Reichlin S. 7.  1986. Somatostatin: historical aspects. Scand. J. Gastroenterol. Suppl. 119:1–10 [Google Scholar]
  8. Collip JB. 8.  1925. The extraction of a parathyroid hormone which will prevent or control parathyroid tetany and which regulates the level of blood calcium. J. Biol. Chem. 63:395–438 [Google Scholar]
  9. Potts JT. 9.  2005. Parathyroid hormone: past and present. J. Endocrinol. 187:311–25 [Google Scholar]
  10. Davidson MB, Bate G, Kirkpatrick P. 10.  2005. Exenatide. Nat. Rev. Drug Discov. 4:713–14 [Google Scholar]
  11. Jeppesen PB. 11.  2013. Modern treatment of short bowel syndrome. Curr. Opin. Clin. Nutr. Metab. Care 16:582–87 [Google Scholar]
  12. Garin MC, Burns CM, Kaul S, Cappola AR. 12.  2013. Clinical review: the human experience with ghrelin administration. J. Clin. Endocrinol. Metab. 98:1826–37 [Google Scholar]
  13. Zac-Varghese S, De Silva A, Bloom SR. 13.  2011. Translational studies on PYY as a novel target in obesity. Curr. Opin. Pharmacol. 11:582–85 [Google Scholar]
  14. Ionut V, Bergman RN. 14.  2011. Mechanisms responsible for excess weight loss after bariatric surgery. J. Diabetes Sci. Technol. 5:1263–82 [Google Scholar]
  15. Le Roux CW, Borg C, Wallis K, Vincent RP, Bueter M. 15.  et al. 2010. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann. Surg. 252:50–56 [Google Scholar]
  16. Chambers AP, Jessen L, Ryan KK, Sisley S, Wilson-Perez HE. 16.  et al. 2011. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 141:950–58 [Google Scholar]
  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error